New needling technique could ease chronic pain without drugs
NCT ID NCT04261959
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tested a non-drug treatment called myoActivation for chronic pain in 41 marginalized people. The therapy uses a structured assessment and needling to release muscle tension. Researchers measured pain, function, and quality of life over 24 weeks to see if it helps.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- myoActivation (a structured assessment and needling technique for myofascial pain)
- What this could lead to
- If it works, this could offer a simple, non-drug option for managing chronic pain in people who have limited access to care.
- What could go wrong
- This is a small pilot study with only 41 participants and no comparison group. Results may not apply to everyone, and the benefits may be modest or temporary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
41 people
The number who actually took part.
- Started
-
Feb 2020
- Finished
-
Aug 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Structurally vulnerable persons (i.e. within marginalized populations) with chronic pain, and typically also mental health issues, substance use disorders, physical and emotional trauma.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Any English-speaking patient with myofascial related chronic pain lasting \>3 months, referred to the Vancouver Community (VC) chronic pain service by primary care. Exclusion Criteria: Any patient who has received any of the following pain interventions or treatment in the 3 months preceding recruitment/intake to the pain service: * Intramuscular Stimulation (IMS); * Trigger Point Injection (TPI) with or without injectate; * External physiotherapy (i.e. outside the service offered at VC pain clinic); * Massage; * Joint injection; * Chiropractic; * Acupuncture; * Group counselling at VC Pain Service (or has an existing appointment to attend Group counselling). (note, exclusion list does not include pain medications or opioid replacement therapy; also note, patients who subsequently access the VC Pain Service Group counselling will continue to be included in the study)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pain, chronic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vancouver Community Pain Service, 524 East Pender Street
Vancouver, British Columbia, V6A 1V3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Muscle therapy may restore strength in dialysis patients
- Does pain beyond the knee signal bigger mobility loss?
- Your DNA may hold the key to personalized pain relief
- Which injection eases knee pain better: steroid or sugar?
- Can we predict chronic pain after breast cancer surgery?
- Teaching doctors to talk about pain: a new approach to safer opioid prescribing